Adia Nutrition Inc., a company focused on advancing stem cell therapies, has announced the identification of over 20 million shares that were potentially improperly issued. As part of an ongoing review of its historical share structure, the company has initiated legal proceedings to cancel these shares and return them to its treasury. This action follows a comprehensive internal audit and is supported by the company's legal counsel. Updates on the legal proceedings will be provided as they progress.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adia Nutrition Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 265004) on September 04, 2025, and is solely responsible for the information contained therein.